Shigella is an enteric pathogen that causes dysentery in humans. The pathogen is most often acquired by ingestion of contaminated food or water. The annual number of Shigella episodes throughout the world is thought to exceed 150 million. Greater than 90% of the cases occur in developing third world countries. The number of deaths attributed to Shigella exceeds one million per year. The majority of the casualties (>65%) are children under the age of five. Although the mechanism by which Shigella species cause the disease is still not fully understood, the strong inflammatory reaction characteristic to Shigellosis provides a strong indication that host inflammatory cells play a key role relative to the onset of the disease. We hypothesize that Shigella has developed strategies to kills host macrophages and neutrophils in order to survive its first encounter with the host immune surveillance system. The overall goal of studies described in this application is to develop an understanding of the mechanism by which Shigella kills host, human macrophage. Data obtained by the applicants strongly argue that Shigella triggers a non-apoptotic death of human macrophages while Shigella-infected human monocytes die by an accelerated apoptotic process. The studies proposed will test the hypotheses that Shigella-infected macrophages die by a necrotic/non-apoptotic mechanism that i) results from the production of reactive oxygen intermediates that cause the destruction of the mitochondria and/or ii) that a protein produced by virulent Shigella specifically targets the host-cell's mitochondria for destruction. The studies proposed will address two specific aims.
Aim 1 : Is the non-apoptotic death of human macrophages triggered by virulent Shigella linked to, and dependent on, the production of reactive oxygen intermediates by the infected cells? Aim 2: Is the response of human macrophages to Shigella dependent on the Shigella protein IpgBl?

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Small Research Grants (R03)
Project #
1R03AI053202-01
Application #
6557826
Study Section
Bacteriology and Mycology Subcommittee 2 (BM)
Program Officer
Van de Verg, Lillian L
Project Start
2002-09-17
Project End
2004-09-16
Budget Start
2002-09-17
Budget End
2003-09-16
Support Year
1
Fiscal Year
2002
Total Cost
$77,750
Indirect Cost
Name
University of Medicine & Dentistry of NJ
Department
Surgery
Type
Schools of Medicine
DUNS #
622146454
City
Piscataway
State
NJ
Country
United States
Zip Code
08854
Haimovich, Beatrice; Venkatesan, Malabi M (2006) Shigella and Salmonella: death as a means of survival. Microbes Infect 8:568-77
Koterski, James F; Nahvi, Massoumeh; Venkatesan, Malabi M et al. (2005) Virulent Shigella flexneri causes damage to mitochondria and triggers necrosis in infected human monocyte-derived macrophages. Infect Immun 73:504-13